Surmodics, Inc. (SRDX) Financial Statements (2024 and earlier)

Company Profile

Business Address 9924 W 74TH ST
EDEN PRAIRIE, MN 55344
State of Incorp. MN
Fiscal Year End September 30
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,35244,57919,18026,43018,99822,086
Cash and cash equivalents41,41944,57919,18026,43018,99820,074
Short-term investments3,933    2,012
Receivables11,34111,75212,12010,18912,89011,791
Inventory, net of allowances, customer advances and progress billings14,83914,61013,76712,72411,81910,926
Inventory14,83914,61013,76712,72411,81910,926
Prepaid expense2,6002,9614,0343,8092,5703,208
Other undisclosed current assets12,55911,94812,14311,31011,31012,024
Total current assets:86,69185,85061,24464,46257,58760,035
Noncurrent Assets
Property, plant and equipment26,02626,57127,61427,71727,14828,289
Intangible assets, net (including goodwill)69,15271,64272,54972,57068,85573,342
Goodwill42,94643,84443,82343,30840,71042,590
Intangible assets, net (excluding goodwill)26,20627,79828,72629,26228,14530,752
Deferred income tax assets      8,479
Other noncurrent assets3,8644,8384,7565,0064,7695,507
Total noncurrent assets:99,042103,051104,919105,293100,772115,617
TOTAL ASSETS:185,733188,901166,163169,755158,359175,652
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,4377,93710,2519,08317,91915,380
Employee-related liabilities8,9297,595
Accounts payable2,9932,4843,7882,0353,1361,928
Accrued liabilities6,4445,4536,4637,0485,8545,857
Deferred revenue4,3784,3283,3463,7714,1604,007
Debt     10,00010,000
Other undisclosed current liabilities10,13919,7835,5334,410  
Total current liabilities:23,95432,04819,13017,26432,07929,387
Noncurrent Liabilities
Long-term debt and lease obligation    29,495  
Long-term debt, excluding current maturities    29,495  
Liabilities, other than long-term debt12,46415,08815,17615,73517,88821,153
Deferred revenue2,4003,4923,4094,1155,0887,402
Deferred income tax liabilities2,0042,0572,0252,1022,0272,227
Other liabilities8,0609,5399,7429,51810,77311,524
Other undisclosed noncurrent liabilities29,40529,35329,303   
Total noncurrent liabilities:41,86944,44144,47945,23017,88821,153
Total liabilities:65,82376,48963,60962,49449,96750,540
Equity
Equity, attributable to parent119,910112,412102,554107,261108,392125,112
Common stock708707707706701700
Additional paid in capital36,70634,34532,44630,22428,77426,612
Accumulated other comprehensive loss(4,759)(3,201)(3,814)(4,617)(9,874)(5,719)
Retained earnings87,25580,56173,21580,94888,791103,519
Total equity:119,910112,412102,554107,261108,392125,112
TOTAL LIABILITIES AND EQUITY:185,733188,901166,163169,755158,359175,652

Income Statement (P&L) ($ in thousands)

12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
Revenues27,97052,48327,19824,93325,98824,854
Cost of revenue(7,917)(6,965)(6,605)(6,180)(6,575)(6,165)
Cost of goods and services sold(7,039)(6,921)(5,738)(5,267)(5,597)(5,141)
Gross profit:20,05345,51820,59318,75319,41318,689
Operating expenses(22,503)(24,106)(27,176)(25,982)(26,026)(25,832)
Operating income (loss):(2,450)21,412(6,583)(7,229)(6,613)(7,143)
Nonoperating expense(339)(763)(782)(779)(179)(38)
Investment income, nonoperating5461821771722622
Gain (loss), foreign currency transaction, before tax10(61)(75)(125)(17)85
Interest and debt expense(895)(884)(884)(826)(188)(145)
Income (loss) from continuing operations before equity method investments, income taxes:(3,684)19,765(8,249)(8,834)(6,980)(7,326)
Other undisclosed income from continuing operations before income taxes895884884826188145
Income (loss) from continuing operations before income taxes:(2,789)20,649(7,365)(8,008)(6,792)(7,181)
Income tax expense (benefit)9,483(13,303)(368)165(7,936)1,530
Income (loss) from continuing operations:6,6947,346(7,733)(7,843)(14,728)(5,651)
Loss before gain (loss) on sale of properties:(14,728)(5,651)
Net income (loss) available to common stockholders, diluted:6,6947,346(7,733)(7,843)(14,728)(5,651)

Comprehensive Income ($ in thousands)

12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
Net income (loss):6,6947,346(7,733)(7,843)(14,728)(5,651)
Other comprehensive income (loss)(1,558)6138035,257(4,155)(4,285)
Comprehensive income (loss), net of tax, attributable to parent:5,1367,959(6,930)(2,586)(18,883)(9,936)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: